Drug intelligence / Profile preview

patupilone

Development stage
Phase 3
Lead developer
Novartis
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Patupilone is a 16-membered ring macrolide belonging to the epothilone class of anticancer agents. It is a natural secondary metabolite isolated from the myxobacterium Sorangium cellulosum. Patupilone acts as a microtubule stabilizer by binding to the αβ-tubulin heterodimer subunit at the same site as paclitaxel (taxol), promoting tubulin polymerization and stabilizing microtubules. This leads to inhibition of microtubule function, cell cycle arrest at the G2-M transition phase, and ultimately apoptosis of cancer cells. Patupilone was investigated for use in various cancers including ovarian cancer, lung cancer, brain cancer, breast cancer, gastric cancer, colorectal cancer and prostate cancer. Despite promising preclinical activity and early-phase clinical trials showing some tumor control in heavily pretreated patients with metastatic disease (notably colorectal and ovarian cancers), later-stage trials failed to demonstrate significant efficacy or survival benefit over standard therapies; development was discontinued due to lack of efficacy and high toxicity[1][3][5][6][8][10].

Other names
epothilone BEPO906EPO-906EPO 906
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on patupilone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on patupilone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call